Reata Pharmaceuticals Correlations
| RETADelisted Stock | USD 172.36 0.02 0.01% |
The correlation of Reata Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reata Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reata Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Very good diversification
The correlation between Reata Pharmaceuticals and NYA is -0.21 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reata Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.
Reata |
The ability to find closely correlated positions to Reata Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reata Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reata Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reata Pharmaceuticals to buy it.
Moving together with Reata Stock
| 0.8 | CAT | Caterpillar Financial Report 6th of August 2024 | PairCorr |
| 0.93 | MMM | 3M Company Financial Report 23rd of July 2024 | PairCorr |
| 0.88 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.75 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
| 0.81 | CVX | Chevron Corp Financial Report 26th of July 2024 | PairCorr |
| 0.85 | BAC | Bank of America Aggressive Push | PairCorr |
Moving against Reata Stock
| 0.86 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
| 0.83 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.7 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.69 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.61 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.55 | BKRKY | Bank Rakyat | PairCorr |
| 0.41 | HD | Home Depot Earnings Call Tomorrow | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Reata Stock performing well and Reata Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Reata Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | 1.42 | 0.04 | 0.00 | 0.14 | 1.98 | 2.97 | 14.76 | |||
| MRTX | 0.34 | 0.07 | (0.05) | (0.32) | 0.16 | 0.93 | 2.20 | |||
| KRYS | 2.77 | 0.54 | 0.20 | 0.54 | 2.16 | 5.24 | 45.71 | |||
| ICPT | 3.13 | 1.21 | 0.50 | 2.88 | 1.31 | 4.60 | 83.17 | |||
| PTCT | 2.67 | 0.26 | 0.14 | 0.19 | 2.35 | 6.25 | 19.51 | |||
| MDGL | 3.60 | 0.04 | 0.03 | 0.09 | 4.32 | 8.89 | 24.70 | |||
| CVAC | 2.66 | (0.34) | 0.00 | (0.13) | 0.00 | 4.68 | 18.75 | |||
| VIR | 2.71 | (0.07) | 0.02 | 0.05 | 3.35 | 7.86 | 18.31 | |||
| PPCB | 12.38 | (1.58) | 0.00 | (0.38) | 0.00 | 29.41 | 77.78 |
Reata Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reata Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reata Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reata Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Reata Pharmaceuticals Corporate Management
Elected by the shareholders, the Reata Pharmaceuticals' board of directors comprises two types of representatives: Reata Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reata. The board's role is to monitor Reata Pharmaceuticals' management team and ensure that shareholders' interests are well served. Reata Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reata Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christian Wigley | VP Officer | Profile | |
| Bhaskar Anand | VP Officer | Profile | |
| Dawn Bir | Chief Commercial Officer | Profile | |
| Colin MD | Ex Officer | Profile | |
| Manmeet Soni | CFO COO | Profile |
Still Interested in Reata Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |